SEC FORM 3

SEC FORM 3 SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Palmer Craig E.

(Last)

(First)

(Middle)

9201 W BROADWAY AVE #650

(Street)

MINNEAPOLIS

55445

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/21/2022

3. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP, U.S. Sales

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	⁽¹⁾	02/15/2028	Common Stock	75	0.237	D
Stock Option	⁽¹⁾	02/15/2028	Common Stock	4,425	0.237	D
Stock Option	⁽²⁾	02/15/2028	Common Stock	4,425	0.237	D
Stock Option	⁽³⁾	11/11/2023	Common Stock	295	0.237	D
Stock Option	⁽³⁾	09/10/2024	Common Stock	379	0.237	D
Stock Option	⁽³⁾	06/30/2025	Common Stock	404	0.237	D
Stock Option	⁽³⁾	08/06/2025	Common Stock	151	0.237	D
Stock Option	⁽³⁾	07/12/2026	Common Stock	1,264	0.237	D
Stock Option	⁽³⁾	09/27/2026	Common Stock	1,896	0.237	D
Stock Option	⁽³⁾	12/07/2026	Common Stock	75	0.237	D
Stock Option	⁽³⁾	07/12/2027	Common Stock	151	0.237	D
Stock Option	⁽³⁾	10/31/2027	Common Stock	151	0.237	D
Stock Option	⁽³⁾	12/14/2027	Common Stock	75	0.237	D
Stock Option	⁽⁴⁾	07/02/2028	Common Stock	1,593	0.395	D
Stock Option	⁽⁵⁾	07/12/2028	Common Stock	303	0.395	D
Stock Option	⁽⁶⁾	10/07/2028	Common Stock	303	1.186	D
Stock Option	⁽⁷⁾	07/23/2029	Common Stock	5,335	3.955	D
Stock Option	⁽⁷⁾	07/23/2029	Common Stock	11,732	3.955	D
Stock Option	⁽³⁾	09/30/2030	Common Stock	7,636	4.35	D
Stock Option	⁽⁸⁾	09/30/2030	Common Stock	6,844	4.35	D
Stock Option	⁽⁹⁾	09/30/2030	Common Stock	981	4.35	D
Stock Option	⁽⁹⁾	09/30/2030	Common Stock	5,800	4.35	D
Stock Option	⁽¹⁰⁾	02/03/2031	Common Stock	10,114	7.119	D
Stock Option	⁽¹⁰⁾	02/03/2031	Common Stock	11,241	7.119	D
Stock Option	⁽¹⁰⁾	02/03/2031	Common Stock	3,930	7.119	D
Stock Option	⁽¹¹⁾	06/28/2031	Common Stock	12,644	18	D
Stock Option	⁽¹¹⁾	06/28/2031	Common Stock	16,456	18	D
Stock Option	⁽¹²⁾	01/17/2032	Common Stock	38,200	9.08	D
Stock Option	⁽¹³⁾	09/30/2030	Common Stock	7,527	4.35	D

Explanation of Responses:

1. Vested as to 25% of the shares on February 16, 2019 and vests as to 1/48th of the shares each month thereafter.

2. Vested as to 25% of the shares on January 28, 2020 and vests as to 1/48th of the shares each month thereafter.

3. Fully exercisable.

4. Vested as to 25% of the shares on July 3, 2019 and as to 1/48th of the shares each month thereafter.

5. Vested as to 25% of the shares on July 13, 2019 and as to 1/48th of the shares each month thereafter.

6. Vested as to 25% of the shares on October 8, 2019 and as to 1/48th of the shares each month thereafter.

7. Vested as to 25% of the shares on July 24, 2020 and as to 1/48th of the shares each month thereafter.

8. Vested as to 25% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.

9. Vested as to 25% of the shares on October 1, 2021 and as to 1/48th of the shares each month thereafter.

10. Vests as to 25% of the shares on February 4, 2022 and as to 1/48th of the shares each month thereafter.

11. Vests as to 25% of the shares on June 29, 2022 and as to 1/48th of the shares each month thereafter.

12. Vests as to 25% of the shares on January 18, 2023 and as to 1/48th of the shares each month thereafter.

13. Vested as to 75% of the shares on October 1, 2020 and as to 1/48th of the shares each month thereafter.

	/s/ Amy C. Seidel, Attorney-in-Fact	01/28/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.